Current status of glucocorticoid usage in solid organ transplantation

查看全文 作　　者：Simin Dashti-[1]Khavidaki;Reza [2]Saidi;Hong [3]Lu

机构地区：[1]Department of Clinical Pharmacy,Faculty of Pharmacy,Tehran University of Medical Sciences,Tehran 14155,Iran;[2]Department of Surgery,SUNY Upstate Medical University,Syracuse,NY 13210,United States;[3]Department of Pharmacology,SUNY Upstate Medical University,Syracuse,NY 13210,United States

出　　处：《World Journal of Transplantation》索引2021年第11卷第11期,共23页

摘　　要：Glucocorticoids(GCs)have been the mainstay of immunosuppressive therapy in solid organ transplantation(SOT)for decades,due to their potent effects on innate immunity and tissue protective effects.However,some SOT centers are reluctant to administer GCs long-term because of the various related side effects.This review summarizes the advantages and disadvantages of GCs in SOT.PubMed and Scopus databases were searched from 2011 to April 2021 using search syntaxes covering“transplantation”and“glucocorticoids”.GCs are used in transplant recipients,transplant donors,and organ perfusate solution to improve transplant outcomes.In SOT recipients,GCs are administered as induction and maintenance immunosuppressive therapy.GCs are also the cornerstone to treat acute antibody-and T-cell-mediated rejections.Addition of GCs to organ perfusate solution and pretreatment of transplant donors with GCs are recommended by some guidelines and protocols,to reduce ischemia-reperfusion injury peri-transplant.GCs with low bioavailability and high potency for GC receptors,such as budesonide,nanoparticle-mediated targeted delivery of GCs to specific organs,and combination use of dexamethasone with inducers of immuneregulatory cells,are new methods of GC application in SOT patients to reduce side effects or induce immune-tolerance instead of immunosuppression.Various side effects involving different non-targeted organs/tissues,such as bone,cardiovascular,neuromuscular,skin and gastrointestinal tract,have been noted for GCs.There are also potential drug-drug interactions for GCs in SOT patients. 关键词：CORTICOSTEROIDS GLUCOCORTICOIDS Solid organ transplantation Liver KIDNEY Heart LUNG

相关文献

参考文献（144）
引证文献（5）
耦合文献（2）

参考文献(144)

引证文献(5)

耦合文献(2)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Current status of glucocorticoid usage in solid organ transplantation

参考文献(144)

引证文献(5)

耦合文献(2)

用户提示